Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with Concurrent Chemoradiation in Nasopharyngeal Carcinoma
NCT02537925Phase 3Unknown
- Start
- Jan 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib oral solution in nasopharyngeal carcinoma (NPC). Status: unknown.
02
Drugs
celecoxib oral solution
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02537925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02537925.